Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma | SpringerLink
Disertační práce
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Immortal time bias - Catalog of Bias
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
What do clinical trial results mean? | Cancer Research UK
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Event Free Survival - an overview | ScienceDirect Topics
Frontiers | Iron Deficiency: A New Target for Patients With Heart Failure
:max_bytes(150000):strip_icc()/doctor-pleased-with-elderly-couple-s-test-results-1062184558-5d2916799be84a31838da74c74397e37.jpg "Understanding Event-Free Survival (EFS) After Treatment")
Understanding Event-Free Survival (EFS) After Treatment
Differences in overall survival (OS) (A), event-free survival (EFS)... | Download Scientific Diagram
A) Event-free survival (EFS), (B) disease-free survival (DFS), and (C)... | Download Scientific Diagram
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma | SpringerLink
In this edition Also - Eurosurveillance
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
The Significance of Progression-Free Survival as a Clinical End Point in Oncology
Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram
A, C Event-free survival and B, D overall survival according to the... | Download Scientific Diagram
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party | SpringerLink
Event Free Survival - an overview | ScienceDirect Topics
